Jeroen J. W. M. Janssen

机构：Radboud University Nijmegen, Radboud University Medical Center · ORCID：0000-0001-9567-1955

发表论文 274 篇 · 总被引 6612 次 · h-index 42

代表论文

• 2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia (2025 · Leukemia · 被引 110)
• Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results (2024 · Leukemia · 被引 55)
• Dose selection of novel anticancer drugs: exposing the gap between selected and required doses (2024 · The Lancet Oncology · 被引 18)
• Asciminib in combination with imatinib, nilotinib, or dasatinib in patients with chronic myeloid leukemia in chronic or accelerated phase: phase 1 study final results (2025 · Leukemia · 被引 13)
• Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial (2024 · Leukemia · 被引 12)
• Varying concentrations of tyrosine kinase inhibitors in chronic myeloid leukemia patients following bariatric surgery: a case series (2024 · Annals of Hematology · 被引 9)